Literature DB >> 6512268

Sister chromatid exchange in patients treated with methotrexate for psoriasis.

R Lindskov, H C Wulf, G L Wantzin, E Niebuhr.   

Abstract

Sister chromatid exchange (SCE), which is considered a sensitive method in evaluation of mutagenicity and may be an indicator of carcinogenicity, was determined in lymphocytes from 8 patients with severe psoriasis who underwent treatment with oral methotrexate (MTX). During the treatment period (median 118 days, range 50-298 days) a significant increase in SCE compared to the pretreatment value was found in 1 patient only. It is concluded that no long-term damage as measured by SCE occurs in lymphocytes from psoriasis patients treated with MTX.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512268     DOI: 10.1111/1523-1747.ep12260950

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

Review 1.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 2.  Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate.

Authors:  C Bologna; M C Picot; C Jorgensen; P Viu; R Verdier; J Sany
Journal:  Ann Rheum Dis       Date:  1997-02       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.